<DOC>
	<DOCNO>NCT02627248</DOCNO>
	<brief_summary>RATIONALE : Huaier ( Trametes robiniophila Murr ) traditional Chinese medicine , widely use China many year . The investigator find Huaier could exert synergistic effect Epirubicin , Cyclophosphamide , Paclitaxel breast cancer cell . It yet know whether combination chemotherapy effective give together Huaier neoadjuvant setting . PURPOSE : To evaluate effect treatment Huaier Granule manage locally advance breast cancer synergistic action neoadjuvant chemotherapy .</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy With Without Huaier Granule Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>Age : ≥ 18 , female ; Breast cancer ( TNM II , III , IV ) large 2cm maximal diameter able benefit neoadjuvant chemotherapy ; Ductal lobular histological type breast tumor ; The diagnosis breast cancer confirm pathological examination ; The liver kidney function satisfies follow condition within 3 day surgery ( exclude day 3 ) : aspartate aminotransferase ( AST ) , glutamicoxalacetic transaminase ( ALT ) &lt; 2 upper limit normal ( ULN ) , total bilirubin ≤ 1.5 ULN , serum creatinine &lt; 1.5 ULN ; Other laboratory test meet following requirement within 3 day surgery ( exclude day 3 ) : Hb ≥ 90g/l , platelet count ≥ 100×109/L , absolute neutrophil count &gt; 1.5×109/L ; The expect survival time ≥ 8 month ; The subject volunteer sign inform consent . Breast cancer rare histological type ( ductal lobular ) ; Noninvasive cancer ; Presence organ , bone , skin metastasis ; Pregnant lactate woman ; Those active bleeding due various reason ; Those HIV infection AIDSassociated diseases ; Those severe acute chronic disease ; Those severe diabetes ; Those serious infectious disease ; Those take drug oral route ; Drug abuser psychological mental disease may interfere study compliance ; Conditions consider suitable study investigator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>